Taiwan · Delayed Price · Currency is TWD Heron Neutron Medical Statistics
Total Valuation
TPE:7799 has a market cap or net worth of TWD 113.14 billion. The enterprise value is 101.81 billion.
| Market Cap | 113.14B |
| Enterprise Value | 101.81B |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPE:7799 has 156.49 million shares outstanding. The number of shares has increased by 16.38% in one year.
| Current Share Class | 156.49M |
| Shares Outstanding | 156.49M |
| Shares Change (YoY) | +16.38% |
| Shares Change (QoQ) | +2.79% |
| Owned by Insiders (%) | 0.62% |
| Owned by Institutions (%) | 4.14% |
| Float | 83.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20,474.27 |
| PB Ratio | 9.34 |
| P/TBV Ratio | 9.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -216.34 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -218.77 |
Financial Position
The company has a current ratio of 450.86, with a Debt / Equity ratio of 0.00.
| Current Ratio | 450.86 |
| Quick Ratio | 444.37 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -3,340.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -3.96% |
| Revenue Per Employee | 92,100 |
| Profits Per Employee | -7.84M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 762.60 |
| 200-Day Moving Average | 578.32 |
| Relative Strength Index (RSI) | 53.63 |
| Average Volume (20 Days) | 624,148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:7799 had revenue of TWD 5.53 million and -470.61 million in losses. Loss per share was -3.34.
| Revenue | 5.53M |
| Gross Profit | -20.97M |
| Operating Income | -481.07M |
| Pretax Income | -470.61M |
| Net Income | -470.61M |
| EBITDA | -457.81M |
| EBIT | -481.07M |
| Loss Per Share | -3.34 |
Balance Sheet
The company has 11.34 billion in cash and 8.46 million in debt, giving a net cash position of 11.33 billion or 72.40 per share.
| Cash & Cash Equivalents | 11.34B |
| Total Debt | 8.46M |
| Net Cash | 11.33B |
| Net Cash Per Share | 72.40 |
| Equity (Book Value) | 12.11B |
| Book Value Per Share | 77.37 |
| Working Capital | 11.52B |
Cash Flow
In the last 12 months, operating cash flow was -434.38 million and capital expenditures -30.99 million, giving a free cash flow of -465.37 million.
| Operating Cash Flow | -434.38M |
| Capital Expenditures | -30.99M |
| Free Cash Flow | -465.37M |
| FCF Per Share | -2.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | -8,705.52% |
| Pretax Margin | -8,516.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPE:7799 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.38% |
| Shareholder Yield | -16.38% |
| Earnings Yield | -0.42% |
| FCF Yield | -0.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |